PK

Pranshu Kumar Dubey

Active Director Designated Partner DIN 08980899
DIN 08980899 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Pranshu Kumar Dubey

Data last updated:

Pranshu Kumar Dubey is a Designated Partner at Dakshah Pharmaceutical Llp (since 2020). The company operates in Pharma.

DIN 08980899
Primary Designation Designated Partner
Industry Pharma
First Appointment 02 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Dec 20202020Active

Board colleagues of Pranshu Kumar Dubey

NameDINCompanyDesignation
Digvijay Singh08980900Dakshah Pharmaceutical LlpDesignated Partner
Ravi Kumar Dubey08960555Dakshah Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dakshah Pharmaceutical Llp
Premium access

Shareholding and investment profile for Pranshu Kumar Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranshu Kumar Dubey

Pranshu Kumar Dubey currently holds 1 directorship: Dakshah Pharmaceutical Llp (Designated Partner, since 02 Dec 2020).

Pranshu Kumar Dubey was first appointed on 02 Dec 2020 as Designated Partner at Dakshah Pharmaceutical Llp.

The current boards of Pranshu Kumar Dubey's companies include Digvijay Singh (Dakshah Pharmaceutical Llp), Ravi Kumar Dubey (Dakshah Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available